2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Liver Outcomes

50.121 - Correlation of MELD and other Parameters with Quantitative Liver Function Capacity measured by the LiMAx test in Cirrhotic Patients before Liver Transplantation

Presenter: Martin, Stockmann, Berlin, Germany
Authors: Lock J., Malinowski M., Biele S., Neuhaus P., Stockmann M.

CORRELATION OF MELD AND OTHER PARAMETERS WITH QUANTITATIVE LIVER FUNCTION CAPACITY MEASURED BY THE LIMAX TEST IN CIRRHOTIC PATIENTS BEFORE LIVER TRANSPLANTATION

LIVER - OUTCOMES

J.F. Lock1, M. Malinowski2, S. Biele1, P. Neuhaus1, M. Stockmann1
1Department Of General, Visceral, And Transplantation Surgery, University Hospital Charité, Berlin/GERMANY, 2Department Of General, Visceral And Transplantation Surgery, University Hospital Charité, Berlin/GERMANY

Body: Introduction: Quantitative liver function can be determined by the LiMAx test based on the maximal capacity of cytochrome P450 1A2. Its diagnostic performance has been demonstrated recently in liver surgery and transplantation. Hereby the first analysis of patients with cirrhosis is presented. The aim was to explore the correlation of LiMAx versus MELD and Child-Pugh score. Methods: Seventy-four patients were prospectively enrolled before surgery. The LiMAx test was performed by IV application of 2 mg/kg 13C-methacetin and a consecutive breath analysis of 60 minutes (readout shown in [µg/kg/h]; normal values > 315) as described before (Stockmann et al. Ann Surg 2009). Three patients with acute liver failure and another with cholangiocarcinoma in non-cirrhotic liver were excluded. Nonparametric analysis was done by Spearmen’s rank correlation coefficient and Mann-Whitney test. Data is shown as median with interquartile range. Results: Seventy patients (46 male, 24 female; 54 [48-60] years) with hepatitis C (n=21), alcoholic (n=21), or biliary cirrhosis (n=12), hepatocellular carcinoma (n=6), and other liver diseases (n=10) were analyzed. The reported MELD score was 15 (11-20), the length of time on the waiting list was 36 (10-68) weeks. Histo-pathological examination revealed fibrosis grade VI (n=62), V (n=5) and IV (n=3) according to the classification of Ishak et al. Pretransplant LiMAx was 103 (56-174) µg/kg/h. Patients with carcinoma (n=13) revealed higher LiMAx readouts of 169 (121-232) vs. 95 (46-151) µg/kg/h (P=0.010). LiMAx readouts were correlated with reported MELD (r=0.530; P<0.0001) and with pretransplant labMELD (0.692; P<0.0001). A similar correlation was observed with Child-Pugh score (r=0.707; P<0.0001). In addition, significant correlations were observed for serum bilirubin, albumine, INR but not for creatinine. Conclusion: LiMAx readouts are strongly correlated with established parameters of liver function before transplantation. The LiMAx test might be a valuable tool for the assessment of disease severity in liver cirrhosis.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada